Turnover of nitrogen during decomposition of corn and soybean residue in soil

Mineralization and immobilization of N often occur simultaneously in soils, and this results in a turnover of N within pools of inorganic and organic N. Measurement of mineralization-immobilization turnover provides important information about N transformations in soil. Failure to consider the effects of this turnover, however, introduces errors in interpretations of [superscript]15N-tracer studies of transformations and movement of N in soils. Laboratory studies were conducted under controlled conditions to learn more about factors affecting amounts of turnover of N in soils used for corn production;Studies involving additions of various amounts of corn residue and [superscript]15N-labeled nitrate showed that mineralization-immobilization turnover was largely the result of sequential immobilization and mineralization rather than simultaneous processes. Moreover, availability of N in soil influenced rates of immobilization and microbial growth efficiencies occurring during the initial stages of decomposition, rates of mineralization occurring during the latter stages of decomposition, and the amount of turnover that occurred. These observations offer a rational explanation for existing confusion associated with phenomena often called priming effects and added N interactions. Studies showed that fixation and release of ammonium from clay minerals is another source of turnover of N in soils and that failure to recognize this turnover can result in an overestimation of mineralization-immobilization turnover;Studies of mineralization-immobilization turnover in soils having varied cropping histories showed that the period of immobilization during the early stages of decomposition varied in length and could extend into the next cropping season under field conditions. Observed differences in rates and amounts of immobilization during the decomposition of corn and soybean residues provide a reasonable explanation as to why corn grown after soybean requires less fertilizer than does corn grown after corn. They also provide a rational explanation as to why high rates of N fertilization promote loss of soil organic matter. Overall, the results demonstrate that a better understanding of the factors affecting mineralization-immobilization turnover in soils should help predict N availability within cropping seasons and the changes in concentrations of soil organic matter that occur across many cropping seasons

Plasma-photonic spatiotemporal synchronization of relativistic electron and laser beams

Modern particle accelerators and their applications increasingly rely on precisely coordinated interactions of intense charged particle and laser beams. Femtosecond-scale synchronization alongside micrometre-scale spatial precision are essential e.g. for pump-probe experiments, seeding and diagnostics of advanced light sources and for plasma-based accelerators. State-of-the-art temporal or spatial diagnostics typically operate with low-intensity beams to avoid material damage at high intensity. As such, we present a plasma-based approach, which allows measurement of both temporal and spatial overlap of high-intensity beams directly at their interaction point. It exploits amplification of plasma afterglow arising from the passage of an electron beam through a laser-generated plasma filament. The corresponding photon yield carries the spatiotemporal signature of the femtosecond-scale dynamics, yet can be observed as a visible light signal on microsecond-millimetre scales

Electron bunch generation from a plasma photocathode

Plasma waves generated in the wake of intense, relativistic laser or particle beams can accelerate electron bunches to giga-electronvolt (GeV) energies in centimetre-scale distances. This allows the realization of compact accelerators having emerging applications, ranging from modern light sources such as the free-electron laser (FEL) to energy frontier lepton colliders. In a plasma wakefield accelerator, such multi-gigavolt-per-metre (GV m$^{-1}$) wakefields can accelerate witness electron bunches that are either externally injected or captured from the background plasma. Here we demonstrate optically triggered injection and acceleration of electron bunches, generated in a multi-component hydrogen and helium plasma employing a spatially aligned and synchronized laser pulse. This ''plasma photocathode'' decouples injection from wake excitation by liberating tunnel-ionized helium electrons directly inside the plasma cavity, where these cold electrons are then rapidly boosted to relativistic velocities. The injection regime can be accessed via optical density down-ramp injection, is highly tunable and paves the way to generation of electron beams with unprecedented low transverse emittance, high current and 6D-brightness. This experimental path opens numerous prospects for transformative plasma wakefield accelerator applications based on ultra-high brightness beams

The Changing Landscape for Stroke\ua0Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

Background GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non\u2013vitamin K antagonist oral anticoagulant (NOAC), became available. Objectives This study sought to describe phase 2 baseline data and compare these with the pre-NOAC era collected during phase 1. Methods During phase 2, 15,641 consenting patients were enrolled (November 2011 to December 2014); 15,092 were eligible. This pre-specified cross-sectional analysis describes eligible patients\u2019 baseline characteristics. Atrial fibrillation disease characteristics, medical outcomes, and concomitant diseases and medications were collected. Data were analyzed using descriptive statistics. Results Of the total patients, 45.5% were female; median age was 71 (interquartile range: 64, 78) years. Patients were from Europe (47.1%), North America (22.5%), Asia (20.3%), Latin America (6.0%), and the Middle East/Africa (4.0%). Most had high stroke risk (CHA2DS2-VASc [Congestive heart failure, Hypertension, Age  6575 years, Diabetes mellitus, previous Stroke, Vascular disease, Age 65 to 74 years, Sex category] score  652; 86.1%); 13.9% had moderate risk (CHA2DS2-VASc = 1). Overall, 79.9% received oral anticoagulants, of whom 47.6% received NOAC and 32.3% vitamin K antagonists (VKA); 12.1% received antiplatelet agents; 7.8% received no antithrombotic treatment. For comparison, the proportion of phase 1 patients (of N = 1,063 all eligible) prescribed VKA was 32.8%, acetylsalicylic acid 41.7%, and no therapy 20.2%. In Europe in phase 2, treatment with NOAC was more common than VKA (52.3% and 37.8%, respectively); 6.0% of patients received antiplatelet treatment; and 3.8% received no antithrombotic treatment. In North America, 52.1%, 26.2%, and 14.0% of patients received NOAC, VKA, and antiplatelet drugs, respectively; 7.5% received no antithrombotic treatment. NOAC use was less common in Asia (27.7%), where 27.5% of patients received VKA, 25.0% antiplatelet drugs, and 19.8% no antithrombotic treatment. Conclusions The baseline data from GLORIA-AF phase 2 demonstrate that in newly diagnosed nonvalvular atrial fibrillation patients, NOAC have been highly adopted into practice, becoming more frequently prescribed than VKA in Europe and North America. Worldwide, however, a large proportion of patients remain undertreated, particularly in Asia and North America. (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation [GLORIA-AF]; NCT01468701

Telemediations

Postprin